ARTICLE | Company News
Aralez sales and marketing update
October 10, 2016 7:00 AM UTC
Aralez launched once-daily Yosprala 325/40 ( PA32540) and Yosprala 81/40 ( PA8140) in the U.S. for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ...